The Clinical Times
The Front Page of Medicine

Latest medical news · page 70

The latest headlines across every section, pulled from official and open-access sources.

WHO · Jul 15, 2026

Global childhood immunization coverage inches forward despite conflict and hesitancy – UNICEF, WHO

In 2025, 90% of infants globally – or nearly 116 million – received at least one dose of a diphtheria, tetanus and pertussis (DTP) vaccine, and 85% – or 110 million – completed the full three-dose series, according to the annual WHO-UNICEF Estimates of National Immunization Coverage (WUENIC) released today.   While both indicators rose by one percentage point from the previous year, global coverage remains one point below 2019 levels – hovering within the same narrow range since 2009.  According to the data, an estimated 13.5 million…

JAMA Network Open · Jul 15, 2026

Errors in Abstract

The Original Investigation titled “Stage IV Breast Cancer Incidence and Survival, 2010-2021,” published on May 12, 2026, was corrected to fix errors in the Abstract Results. The data reported for increases in percentage of stage IV diagnoses in HR-positive/ERBB2-negative, HR-positive/ERBB2-positive, HR-negative/ERBB2-positive, and triple-negative breast cancer were incorrect. This article was corrected online.

JAMA Network Open · Jul 15, 2026

Area-Based Marginalization and Incidence of Childhood Cancer

This cross-sectional study of children living in Ontario, Canada, examines the association between area-based deprivation and the incidence of childhood cancer in a setting with universal access to publicly funded health care.

JAMA Network Open · Jul 15, 2026

Performance of MRI-Based Prostate Cancer Staging

This case-control study evaluates the performance of magnetic resonance imaging (MRI)–based staging vs traditional digital rectal examination–based staging in men undergoing radical prostatectomy.

MedCity News · Jul 14, 2026

Coalition Urges Policymakers to Reject No Surprises Act Enforcement Bill

The Coalition Against Surprise Medical Billing launched a campaign opposing the No Surprises Act Enforcement Act, arguing it would worsen IDR process abuse. The post Coalition Urges Policymakers to Reject No Surprises Act Enforcement Bill appeared first on MedCity News .

ACC (Cardiology) · Jul 14, 2026

CMS Releases 2027 Medicare Physician Fee Schedule Proposed Rule

The Centers for Medicare and Medicaid Services (CMS) released the 2027 Medicare Physician Fee Schedule (PFS) proposed rule on July 14, reducing the PFS conversion factor from $33.5675 to $33.1693 for qualifying alternative payment model (APM) participants and from $33.4009 to $32.8409 for non-qualifying APM participants.

FDA Drugs · Jul 14, 2026

Tawon Liar contains hidden drug ingredient

FDA is advising consumers not to purchase or use Tawon Liar, a product promoted and sold for pain, rheumatism, insomnia, improving the immune system, increasing energy, and lowering cholesterol on various websites, including www.etsy.com, and possibly in some retail stor

FDA Drugs · Jul 14, 2026

Weight Loss Product Notifications

Learn about the warnings for weight loss products that contain hidden drugs and other hidden ingredients.

MedCity News · Jul 14, 2026

After Antibiotic Approval, Spero Pivots to Immunology Aiming to Rival an Amgen Asset

Spero Therapeutics enters immunology with an antibody licensed from Innovent Biologics. The lead indication is a rare autoimmune condition where Spero aims to offer advantages over the Amgen drug that is currently the only approved treatment. The post After Antibiotic Approval, Spero Pivots to Immunology Aiming to Rival an Amgen Asset appeared first on MedCity News .

FDA Drugs · Jul 14, 2026

FDA Approves First Generics of Gilotrif (afatinib) Tablets

The U.S. Food and Drug Administration approved the first generic versions of GILOTRIF (afatinib tablets) for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have non-resistant epidermal growth factor receptor (EGFR) mutations as detected by an FDA-a

← NewerOlder →

Back to the live front page